Redefining
recovery in
critical care
FMS (Functional Magnetic Stimulation) enables deep neuromuscular activation, helping preserve muscle function and prevent atrophy in ICU patients—without effort or discomfort.
Designed for early-stage intervention, where preserving function is critical.
Muscle function can decline quickly. Intervention shouldn't wait.
In the ICU, patients are often immobilized and highly prone to rapid muscle loss. Although early intervention is critical, many solutions cannot be applied at this stage: they depend on patient participation, require direct skin contact, or are difficult to use in closely monitored patients.
Electrostimulation
Limited penetration into deep tissues. Requires direct contact
Lower comfort at effective intensities
Application limited by patient condition
Requires consumables (e.g. electrodes), increasing treatment costs
Deep stimulation without contact
High tolerance, even at elevated intensities
Applicable from early stages, without patient participation
No consumables required, reducing ongoing operating costs
There is a clear gap between what patients need from the start and what conventional therapies actually allow
FMS: neuromuscular activation from the very first moment
FMS (Functional Magnetic Stimulation) uses high-intensity magnetic fields to induce electrical currents in tissues, directly activating nerves and muscles without the need for contact. This enables treatment when other therapies cannot be used.
What it enables in clinical practice:
Induce effective muscle contractions
Apply therapy over clothing, bandages, or immobilization devices
Initiate treatment from early stages
Activate deep muscle groups without patient participation
Key biological effects:
PAIN RELIEF
Analgesic effect in acute and chronic pain.
NON-INVASIVE NEUROMODULATION
Modulation of neural activity to improve control and functional response.
DEEP NEUROMUSCULAR STIMULATION
Effective activation of neuromuscular activity to enhance activation and functional rehabilitation.
BIOLOGICAL AND TISSUE RESPONSE
Supports recovery processes, including muscle and bone tissue.
What happens in the ICU defines recovery
Muscle deterioration during critical care stays has a direct impact on patient outcomes.
Loss of muscle mass is associated with:
- Longer hospital stays
- Slower rehabilitation
- Reduced functional independence after discharge
Maintaining muscle activity from early stages helps preserve function and improves the overall recovery trajectory.
Clinically validated muscle preservation
Significant reduction in muscle loss compared to conventional physiotherapy
Preservation of muscle thickness (measured by ultrasound)
Improved strength in treated muscle groups
Access clinical studies and scientific evidence
Designed for real ICU workflows.
Built for efficiency and better outcomes.
Magneto Care is designed to integrate seamlessly into ICU workflows, enabling consistent delivery of neuromuscular therapy without increasing workload.
Reduce staff dependency
Hands-free application enables treatment without continuous operator involvement
No direct contact required
Enables treatment in critically ill and monitored patients
No consumables, no recurring costs
Eliminates the need for electrodes or disposable components
Preset programmes & customization
Ready-to-use programmes to save time and customize treatments.
Designed for real ICU workflows.
Built for efficiency and better outcomes.
Magneto Care is designed to integrate seamlessly into ICU workflows, enabling consistent delivery of neuromuscular therapy without increasing workload.
Reduce staff dependency
Hands-free application enables treatment without continuous operator involvement
No direct contact required
Enables treatment in critically ill and monitored patients
No consumables, no recurring costs
Eliminates the need for electrodes or disposable components
Preset programmes & customization
Ready-to-use programmes to save time and customize treatments.
Explore how FMS can support early intervention in ICU
Frequently asked questions
Does the patient need to participate actively?
No. Magneto Care induces neuromuscular contractions without voluntary effort, allowing treatment when the patient cannot actively exercise.
Can Magneto Care be used without direct skin contact?
Yes. FMS can be applied over clothing, bandages and casts, without direct skin contact.
Can Magneto Care be used during the early stages of rehabilitation?
Yes. Because treatment does not rely on voluntary muscle activation, Magneto Care can support neuromuscular stimulation even when active exercise is limited, according to the clinician’s judgment.
Are the treatment protocols adjustable?
Yes. Magneto Care includes preset programs, with frequency, intensity and duration adjustable according to the patient’s condition and therapeutic goals.
Does Magneto Care require consumables?
No. Magneto Care operates without consumables or disposable accessories. Once the applicator and protocol are set, treatment does not require continuous operator involvement.